The distribution of capsular polysaccharide antigen (CHO) types, surface-exposed c proteins a (c") and p (cp> and an R-protein antigen was examined in 334 group B streptococci (GBS) isolates from three groups of patients hospitalised in England and Wales or Norway. The isolates were from 108 carriers, 67 cases of neonatal infection and 154 cases of adult infection. Each group contained all CHO types (Ia, Ib, 11,111, IV, V and NT); type I11 strains predominated except in the adult infected group. Strains within each CHO type could be further subdivided by the protein markers into five subtypes by a combined typing system. The proportion of type Ib and type I11 strains in the neonatal infection cases and of type Ib strains in the adult infection cases significantly outnumbered isolates of these serotypes among the carrier strains. Twenty-nine different serovariants were identified; 24, 13 and 23 serovariants among the carrier, neonatal infection and adult infection isolates, respectively. Certain CHO antigen-protein associations were identified, notably those between Ia/ca, Ib/c@ and III/R. The proportion of invasive isolates that expressed protein was not higher than in the carrier isolates. All CHO-type Ib isolates contained a c protein, but 7 % of the Ib isolates did not contain any of these proteins. These findings indicate that this combined typing approach may be useful in examining epidemiological problems associated with GBS.
Introduction
Group B streptococci (GBS) are major causes of neonatal sepsis and meningitis and are also recognised as occasional pathogens in adults.' Traditionally, GBS have been classified or typed serologically on the basis of the capsular polysaccharide (CHO) antigens designated Ia, Ib, I1 and 111. Typability and discrimination in the CHO typing system are poor and, therefore, alternative methods of typing GBS isolates have been explored, e.g., bacteriophage typing,' multilocus enzyme electrophoresis3 and restriction endonuclease analy~is.~?
More recently it has been realised that, in addition to the CHO antigens, GBS may produce surfacelocalised c and R protein antigens.6* ' The c protein was called Ibc protein' and comprises two proteins, the a and / 3 antigen^.^ Both proteins have been characterised extensively. [10] [11] [12] It has been shown that GBS isolates vary in the expression of both a and p protein13 and others have shown a similar picture for the strepto- Received 20 Sept. 1994; accepted 5 Oct. 1994. coccal R protein antigens, of which the R4 protein is particularly prevalent in GBS.14 To date however, there has been no systematic assessment of the typing potential of a system that combines these different serological approaches.
The present study was designed to explore whether the combined use of CHO and protein antigens in a GBS typing system could increase discrimination and typability. A total of 334 GBS strains collected in hospitals in England and Wales and Norway during 1990-1993 was tested and data on serovariant distribution amongst carriers and cases of infection were assessed.
Materials and methods

Isolates examined
Of a total of 334 GBS examined, 233 isolates came from England and Wales and 101 from Norway. The strains were from infected patients or carriers and were referred from different hospitals throughout the two countries, from 1990 to 1993. All patient isolates were from sporadic cases and duplicate out break isolates IP: 54.70.40.11
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were not included. No GBS epidemic was recorded in either country during the period of collection. GBS from carriers (n = 108) were skin isolates from neonates (35) or vaginal isolates (73) from adults. Of the 226 isolates from invasive GBS infection, 68 were from neonates, 45 from blood cultures and 23 from cerebrospinal fluid or pus; of the 158 isolates from adults, 101 were from blood cultures and 57 from pleural effusions or pus.
Preservation and culture
The isolates were preserved in Greaves's medium at -80°C. Preparations of GBS for testing were made from bacteria cultured on blood agar at 37°C for 18 h.
Testing of antigenic markers
The bacteria were identified by the Streptex kit (Murex) as recommended by the manufacturer. For isolates from England and Wales, CHO type was determined by immunodiffusion in agar gel with HCl extracts and rabbit antisera." Isolates from Norway were tested for CHO antigen by a direct immunofluorescent assay with fluorescein isothiocyanateconjugated IgG from rabbit antisera.'' Surface-exposed protein markers of GBS, the c proteins a (c") and p (cq, were tested by an indirect immunofluorescent assay with monoclonal antibodies (MAbs);l7.l8 a presumed R protein was examined by a MAb produced re~ent1y.l~ Slides with GBS were prepared and the tests were performed and interpreted as described previously."
Results
Test performance
Only 25 isolates produced equivocal results when tested for the CHO or protein markers and these were re-examined. Isolates from England and Wales were serotyped by immunodiffusion in agar gel and those from Norway by an immunofluorescent assay; 15 isolates were tested by both methods with similar results. Isolates for CHO and protein markers were subcultured and tested repeatedly for up to 15 years and no reduction in antibody activity has been noted.
Overall serotype and subtype distribution
The CHO type and subtype distribution among GBS from England and Wales and Norway were similar. Of the 334 GBS isolates examined, 303 (91 %) belonged to one of the CHO types Ia, Ib, 11,111, IV or V (table I). The remaining 3 1 (9 YO) isolates were nontypable and have been considered as a separate serotype (type NT). Type I11 occurred most frequently, followed by type Ib, Ia and type 11.
One or two of the protein antigen markers were expressed by 279 (84%) of the isolates4 protein by 171 (51 %) and R protein by 108 (32%). Of the c proteins C" alone occurred with the highest frequency, followed by the cab combination and cb alone. No isolate expressed both c and R proteins.
Strains of all seven CHO types expressed protein, but some of the CHO antigens were more likely to be associated with one or two particular proteins than with other proteins. This association is shown in fig. 1 . The Ia subtype Ia/ca (74% of Ia isolates) greatly outnumbered other Ia subtypes (p < 0.001) and the Ib subtype Ib/c@ (42%) and the type I11 subtype III/R (75%) outnumbered other type Ib and type I11 subtypes (p < 0.001). None of the 71 type Ib strains expressed the R antigen and five (7 YO) of the Ib strains also failed to express c protein. No particular subtype predominated in type I1 strains. Of the protein antigen markers, ca was most widely distributed among isolates of different CHO types; 29 serovariants were found among the 334 isolates (table I) . Tables I1 and I11 show the distribution of the markers in carrier and invasive isolates and fig. 2 illustrates the predominant subtypes within the most Of the 29 different serovariants detected in the whole strain collection, 24 variants were detected among the carrier strains, 13 among the neonatal infection isolates, and 23 among the isolates from adults with GBS infections.
Distribution of CHO and protein markers in GBS of diferent clinical origins
Discussion
The c proteins a and /? have been well documented 1&12 as well as the characters of the MAbs to these proteins used in this study. 17, 18 The identity of the protein targeted by the third MAb is less certain, but some observations are consistent with this being an R protein." Also, work in progress has shown that this MAb cross-reacts with the R4 protein studied by Flores and Ferrieri14 and also with protein Rib described by Stilhammer-Carlemalm et aL20 These data suggested that the target for the anti-R protein MAb is the R4 protein.
The distribution of GBS CHO types in our strain collection largely corresponds with that of other countries.14-*', 22 Type I11 GBS was the most frequent, as in other GBS strain c~l l e c t i o n s .~~*~~~~~ Strains of all seven CHO types included isolates that expressed one or two of the protein markers or neither. Of all the isolates tested, 5 1 YO produced c protein (27 YO a, 6 YO /? and 19% both a and p) and 32% expressed the R protein.
Certain capsular CHO types were associated with particular protein markers : the type Ia antigen with ca, type Ib with the cap combination and type I11 with the R protein." However, each of the protein markers may also be produced by strains of other CHO types consistent with the supposition that expression of the genes encoding these proteins does not depend on synthesis of the favoured CHO antigen. The c proteins a and p can be expressed by the same GBS isolate, most frequently by type Ib isolates.
Simultaneous expression of R and c protein was not detected, although combined expression of these proteins has been reported as a rare event.14 Hitherto it has been considered that type Ib GBS always produce c protein but 7 % of our Ib isolates did not. It is tempting to speculate as to whether these strains harbour c protein gene(s) that are not expressed.
Whereas the CHO antigen determination enabled classification of the 334 isolates into seven different categories, the combination of this typing method with protein antigen testing enabled identification of 29 different serovars; thus the combined approach may prove useful in epidemiological studies of GBS. It is not known how this approach will compare with DNA typing methods used p r e v i o~s l y .~.~
The prevalence of certain CHO types among the invasive isolates was higher than among the carrier strains, particularly type I11 and to a lesser extent Ib strains in infected neonates, and Ib strains in adult infections. Although the individuals from whom the carrier strains were isolated, neonates and adult women, may not match the groups with clinical disease, particularly the adults, who were both women and men, these observations are in accord with the anticipated role of GBS capsular antigens as virulence factors, type Ib and type I11 antigens being potent virulence factors.', 23 An alternative explanation might be that insufficient immunoprotection against type Ib and type I11 GBS is more common than against GBS of other CHO types. The levels of immunoprotection in the populations studied are not known.
Despite the dominance of type Ib and type I11 GBS among the invasive isolates, isolates of all the serotypes, whether they produced protein or not, could be invasive. Also, these results show that the proportion of invasive isolates that expressed a single protein or the cap combination, corresponded to that of the carrier isolates. On the basis of these findings it would seem that the surface-exposed proteins have little if any importance in the virulence of GBS; this was also noted by Chun et aL21 Despite this, reported data have indicated an important role for these proteins as targets for protective 25 Our findings support the notion that expression of invasiveness by GBS requires the interaction of multiple microbial factors, not only the surface-exposed antigens.
In summary, testing of GBS with antibodies to the surface-exposed c proteins and an R protein greatly enhanced the power of the conventional CHO antigen typing system to identify unrelated GBS isolates. Furthermore, the findings are consistent with the role of CHO serotype antigens in the expression of invasiveness by GBS, particularly the type Ib and type
